N-(1-cyanocyclopropyl)-5,5-difluoro-(2S)-(2,2,2-trifluoro-(1s)-(4-fluorophenyl)ethylamino)heptamide | 1017932-17-0

• 英文名称: N-(1-cyanocyclopropyl)-5,5-difluoro-(2S)-(2,2,2-trifluoro-(1s)-(4-fluorophenyl)ethylamino)heptamide
• 英文别名: (S)-N-(1-cyanocyclopropyl)-5,5-difluoro-2-((S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethylamino)heptanamide；(2S)-N-(1-cyanocyclopropyl)-5,5-difluoro-2-[[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino]heptanamide
• CAS: 1017932-17-0
• 化学式: C₁₉H₂₁F₆N₃O
• 分子量: 421.386
• InChiKey: VEXASZIBSQRHHH-GJZGRUSLSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.3
• 重原子数：
  29
• 可旋转键数：
  9
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.58
• 拓扑面积：
  64.9
• 氢给体数：
  2
• 氢受体数：
  9

文献信息

• [EN] DI-FLUORO CONTAINING COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS<br/>[FR] COMPOSÉS CONTENANT UN DI-FLUORO EN TANT QU'INHIBITEURS DE CYSTÉINE PROTÉASE
  申请人：VIROBAY INC

  公开号：WO2009123623A1

  公开（公告）日：2009-10-08

  The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S, and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.

  本发明涉及一种抑制半胱氨酸蛋白酶的化合物，特别是半胱氨酸蛋白酶B、K、L、F和S，因此可用于治疗由这些蛋白酶介导的疾病。本发明涉及包含这些化合物的药物组合物以及其制备方法。
• DI-FLUORO CONTAINING COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS
  申请人：Link John O.

  公开号：US20080293819A1

  公开（公告）日：2008-11-27

  The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S, and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.

  本发明涉及一种抑制半胱氨酸蛋白酶的化合物，特别是抑制蛋白酶B、K、L、F和S，因此对于治疗由这些蛋白酶介导的疾病是有用的。本发明涉及含有这些化合物的制药组合物以及制备它们的方法。
• CATHEPSIN INHIBITORS FOR TREATING MICROGLIA-MEDIATED NEURON LOSS IN THE CENTRAL NERVOUS SYSTEM
  申请人：Booth Robert

  公开号：US20120329837A1

  公开（公告）日：2012-12-27

  The present invention concerns methods of using Cathepsin S inhibitors and compounds of Formula I that are inhibitors of cathepsin S in treating CNS disorders, diseases, and injuries, particularly neurodegenerative conditions. The present invention is directed to pharmaceutical compositions comprising these compounds for treating CNS disorders.

  本发明涉及使用Cathepsin S抑制剂和公式I的化合物作为Cathepsin S抑制剂治疗中枢神经系统疾病、疾病和损伤，特别是神经退行性疾病的方法。本发明涉及制备这些化合物的制药组合物用于治疗中枢神经系统疾病。
• US7893112B2
  申请人：——

  公开号：US7893112B2

  公开（公告）日：2011-02-22
• US8367732B2
  申请人：——

  公开号：US8367732B2

  公开（公告）日：2013-02-05